BCR::ABL1 translocation is the key genetic event of CML, whereas JAK2/MPL/CALR mutations are molecular aberrations of Ph-negative MPNs. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.